Status:
RECRUITING
Evaluation of the Impact of a Collaboration Between Hospital and Community Pharmacists at Hospital Discharge
Lead Sponsor:
Pharmacie des Hopitaux de l'Est Lemanique
Conditions:
Polypharmacy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to evaluate the impact of an enhanced collaboration between a hospital pharmacist and a community pharmacist during hospital discharge. For patients taking multiple medication...
Eligibility Criteria
Inclusion
- Patients admitted to the internal medicine ward for more than 48 hours
- Patients prescribed seven or more drugs at the time of screening
- Patients discharged to home
- Patients able to give informed consent as documented by signature
Exclusion
- Patient discharged to another hospital, nursing home or rehabilitation clinic
- Refusal of the community pharmacy to participate
- Inability to sign consent and follow the procedures of the study, due to language problems, psychological disorders, dementia, alterations of consciousness and lack of judgement
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06902779
Start Date
September 1 2025
End Date
July 1 2026
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Riviera-Chablais, Vaud-Valais
Rennaz, Canton of Vaud, Switzerland, 1847